Embecta Corp. (NASDAQ: EMBCV) stock closed at per share at the end of the most recent trading day (a % change compared to the prior day closing price) with a volume of 0.0000 shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 2029 people. Embecta Corp. CEO is .

The one-year performance of Embecta Corp. stock is %, while year-to-date (YTD) performance is %. EMBCV stock has a five-year performance of %. Its 52-week range is between and , which gives EMBCV stock a 52-week price range ratio of %

Embecta Corp. currently has a PE ratio of 6.40, a price-to-book (PB) ratio of 2.61, a price-to-sale (PS) ratio of 0.00, a price to cashflow ratio of 3.50, a PEG ratio of -, a ROA of 25.50%, a ROC of 74.21% and a ROE of -115.27%. The company’s profit margin is 15.73%, its EBITDA margin is 39.40%, and its revenue ttm is $840.20 Million , which makes it $14.69 revenue per share.

Of the last four earnings reports from Embecta Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Embecta Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Embecta Corp. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Embecta Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Embecta Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Embecta Corp. has a Neutral technical analysis rating based on Technical Indicators (), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Embecta Corp. in the last 12-months were: